Amynas
Wouwstraat 96
2540 Hove
BE
Amynas
Foundation date
23/12/2019
Sector
#Medical TechnologySubsector
Amynas’ lead candidate product is a bio-envelope made of electrospun nanofibers designed to promote healthy tissue growth around the implant (anti-inflammatory and anti-scarring) and reduce the infection rate, resulting in fewer re-admission rates for post-surgical complications.
Upcoming events
All events-
0712 '22
Emerging Applications of Microbes (2nd edition)
Event by: VIB -
1212 '22
Type 2 Immunity in Homeostasis and Disease (2nd edition)
Event by: VIB -
2911 '22
BioFIT 2022
Event by: Eurasanté
Latest news
More news-
Indigo Diabetes announces first participant enrolled in the SHINE clinical trial
18 hours ago
Read more
-
FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome
Tuesday September 27th 2022
Read more
-
Pauwels Consulting takes over Science@Work
Friday September 23rd 2022
Read more